Cargando…
Pretreatment PSA levels affects the completion rate of Ra-223 treatment
The aim of this study was to review our initial experience of using radium 223 (Ra-223) for metastatic castration-resistant prostate cancer (CRPC) and to evaluate whether pretreatment PSA levels correlate with completion of Ra-223 treatment. In addition, we examined change ratios of PSA, ALP and BAP...
Autores principales: | Utsumi, Nobuko, Kurosaki, Hiromasa, Miura, Kosei, Kitoh, Hiroki, Akakura, Koichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979791/ https://www.ncbi.nlm.nih.gov/pubmed/33742050 http://dx.doi.org/10.1038/s41598-021-86033-4 |
Ejemplares similares
-
Author Correction: Pretreatment PSA levels affects the completion rate of Ra-223 treatment
por: Utsumi, Nobuko, et al.
Publicado: (2021) -
Radiotherapy Planning System to Measure Tumor Doubling Time in Cervical Cancer
por: Kurosaki, Hiromasa, et al.
Publicado: (2021) -
A Case of Suspected Radiation Recall Pneumonitis After a COVID-19 Infection
por: Kurosaki, Hiromasa, et al.
Publicado: (2021) -
Use of a Head-Tilting Baseplate During Tomotherapy to Shorten the Irradiation Time and Protect the Hippocampus and Lens in Hippocampal Sparing-Whole Brain Radiotherapy
por: Miura, Kosei, et al.
Publicado: (2021) -
Influence of Modulation Factor on Treatment Plan Quality and Irradiation Time in Hippocampus-Sparing Whole-Brain Radiotherapy Using Tomotherapy
por: Ishibashi, Akihiko, et al.
Publicado: (2021)